Westover Capital Advisors, LLC Abbott Laboratories Transaction History

Westover Capital Advisors, LLC

$513 Million
Q3 2024

A detailed history of Westover Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Westover Capital Advisors, LLC holds 7,690 shares of ABT stock, worth $878,428. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,690

Previous 5,765 33.39%

Holding current value

$878,428

Previous $599,000 46.24%

% of portfolio

0.17%

Previous 0.16%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $192,634 - $227,400	1,925 Added 33.39%	7,690 $876,000
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $318,709 - $355,760	3,164 Added 121.65%	5,765 $599,000
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $1,642 - $1,814	-15 Reduced 0.57%	2,601 $295,000
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $15,422 - $18,878	171 Added 6.99%	2,616 $287,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $218,692 - $243,669	-2,170 Reduced 47.02%	2,445 $266,000
Q1 2023 May 22, 2023	SELL	$96.86 - $114.01 $1,840 - $2,166	-19 Reduced 0.41%	4,615 $467,000
Q4 2022 May 18, 2023	SELL	$95.06 - $111.52 $428,910 - $503,178	-4,512 Reduced 49.33%	4,634 $508,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $10,159 - $11,763	-105 Reduced 1.14%	9,146 $885,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $102,376 - $123,740	-1,003 Reduced 9.78%	9,251 $1.01 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $36,486 - $44,492	-320 Reduced 3.03%	10,254 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $52,104 - $63,798	-451 Reduced 4.09%	10,574 $1.49 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $9,216 - $10,195	-79 Reduced 0.71%	11,025 $1.3 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $37,238 - $43,834	-352 Reduced 3.07%	11,104 $1.29 Million
Q1 2021 May 18, 2021	SELL	$108.84 - $128.23 $84,024 - $98,993	-772 Reduced 6.31%	11,456 $1.37 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $11,025 - $12,014	105 Added 0.87%	12,228 $1.34 Million
Q3 2020 Nov 19, 2020	BUY	$91.64 - $111.29 $62,590 - $76,011	683 Added 5.97%	12,123 $1.32 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $34,992 - $44,786	457 Added 4.16%	11,440 $1.05 Million
Q1 2020 May 18, 2020	BUY	$62.82 - $91.86 $140,214 - $205,031	2,232 Added 25.51%	10,983 $867,000
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $52,523 - $58,470	669 Added 8.28%	8,751 $760,000
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $51,150 - $55,462	625 Added 8.38%	8,082 $676,000
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $543,466 - $633,845	7,457 New	7,457 $627,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westover Capital Advisors, LLC with notifications on news.

Account

Westover Capital Advisors, LLC Abbott Laboratories Transaction History